The Ibex 35 index holds 10,000 points but ends the month lower due to a new Grifols collapse.
The Spanish selection ends February with an avalanche of results. and with luggage 0.74% and from this year 0.89%. The falls reflected from the first hour maintain opening levels that lost strength after the US PCE (consumer inflation) data and which gained momentum again as Grifols A fell sharply in the first hour of late trading.
At the moment, the second month of the year ends for the Ibex 35, maintaining at least 10,000 points, although the laterality present in each of the February sessions does not leave the indicator in the face of better results, including highs. according to a significant part of European indicators.
Thus, IBEX 35 ended the fourth trading session of the week with a decline of 0.67% to 10,001.20 points, with Grifols A falling by 34.93%, Amadeus by 7.33% and Solaria by 5.04% compared to profits Fluidra at 8.61%. %, Laboratorios Rovi – 4.44% and Indra – 3.45%.
Monitor the IBEX 35 price in real time
As a result, they became the main players in the market, cwith a particular impact on both positive and negative quote levels.
The best is Fluidra, which ended 2023 with a profit after tax of 113.8 million euros, which is 28% less than the figures published a year earlier. With sales of €2,051 million, down 14% from the previous year, the company forecasts 2024 sales of €2,000 to €2,150 million, EBITDA of €440 to €490 million and net cash earnings per share of €1.07 to €2,150 million. 1.25. Euro.
But the worst is certainly Grifols A, also the negative hero of the day, despite the fact that he asked the CNMV to speed up the submission of his reports. The blood products company was severely punished, with net profit falling 70% to 59 million euros, which included one-off items of 147 million related to restructuring costs. If not for the extraordinary effect associated with Biotest, the company would have recorded a profit similar to last year’s at $208 million.
But most of all, the drop, which reached 10%, came after new suspicions about Scranton came to light, which brought the value back to its worst levels in January, when it rose the most in February. And the drop, which far exceeded 33% in the last half hour of the session, was caused by Expansión information indicating that orThe company’s subsidiary paid Scranton a €266 million dividend in 2023, coupled with the fact that James Costos, a director of Grifols, did not sign off on the accounts or its auditor, KPMG.
On the negative side, Amadeus has fallen due to a downgrade in CaixaBank BPI’s recommendation, which lowers its recommendation to neutral, although it sets its target price for its securities at €68 per share.
Results were also presented by IAG (Iberia), which earned 2.655 million euros, but excluded the payment of dividends from its accounts for last year. In terms of revenue, the company added 29,453, up 27.7% from 23,066 in 2022. Operating profit for 2023 before exceptional items was €3,507 million, significantly higher than the previous year and higher than 2019.
On a continuous market basis, OHLA ended the 2023 financial year with a profit of 5.5 million euros, which compares with a loss of 96 million recorded a year earlier. In a year in which EBITDA grew at its fastest pace since 2015.
Laboratorios Reig Jofre’s revenue, among others, also increased by 17% and EBITDA by 15%, reaching 35 million euros. Specialty Pharmacare, which specializes in prescription drugs, achieved the highest revenue growth at 31%.
For its part, DIA supermarkets report a reduction in their net losses by 75.6% in 2023, amounting to 30 million euros. The report highlights the negative impact of deteriorating assets in Brazil and strong performance in Spain. Martin Tolkachir, the company’s global CEO, highlighted customer trust and the success of its proximity focus.
And Prosegur increased its consolidated net profit by 1.3% to €66 million on revenue of €4,310 million, up 3.3% year-on-year, with its operations growing organically by 41.8%. In addition, the Group demonstrates excellent operating cash flow with an increase of 9% to €313 million.
Meanwhile in Europe, indicators had a mixed close, with the EURO STOXX 50 index posting its best performance in a month and rising almost 8% in February. Trading ends on Thursday with a slight decline of 0.10% to 4881 points, the CAC 40 index falls by 0.14% to 7942 points. Daxrising at closing for the third day in a row by 0.49% to 17,684 points, while the index London FT 100, it rose 0.06% to 7,628 points.
Follow the price of EURO STOXX 50 in real time
Indicators are rising on Wall StreetAfter a good read of the US PCE data, personal income and spending data inflation behaved as expected, but with year-over-year declines in headline and base rates. Despite overall gains at the open, the Ibex 35 closes at an opening level of 38,949, the S&P 500 is up 0.27% at 5,083 and the Nasdaq OMX is up 0.5% at 16,026. .
As for fixed incomes, they generally fell after the release of US inflation data, after rising in the morning and evening. Spanish 10-year bonds closed down 1.29% to 3.066%, while German bonds lose 2.23% to 2.4045%. The risk premium is adjusted by 1% to 88.35 basis points.
As for oil, it has risen slightly in price future Brent barrel to $82.25 like US West Texas, which rises to $78.75.
For its part, in the euro-dollar, the dollar wins the game this Thursday, depressing the single currency by 0.18% to 1.0816 units. Meanwhile, Bitcoin rose 2.7% to $62,586.
follow quotes and analysis of your favorite stocks , and you will know the recommendations and objective prices of analysts for investing.
In investment strategies We have been helping investors make their investments profitable on a regular basis for over 19 years.